Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors

Fiona Maas*, Suzanne Arends, Elisabeth Brouwer, Ivette Essers, Eveline van der Veer, Monique Efde, Peter M. A. van Ooijen, Rinze Wolf, Nic J. G. M. Veeger, Hendrika Bootsma, Freke R. Wink, Anneke Spoorenberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1011-1019
Number of pages9
JournalArthritis Care and Research
Volume69
Issue number7
DOIs
Publication statusPublished - Jul 2017

Keywords

  • ALPHA BLOCKING THERAPY
  • LONGITUDINAL OBSERVATIONAL COHORT
  • AXIAL SPONDYLOARTHRITIS
  • ANTIBODY INFLIXIMAB
  • STRUCTURAL DAMAGE
  • DISCONTINUATION
  • SELECTION
  • MODEL

Cite this

Maas, F., Arends, S., Brouwer, E., Essers, I., van der Veer, E., Efde, M., van Ooijen, P. M. A., Wolf, R., Veeger, N. J. G. M., Bootsma, H., Wink, F. R., & Spoorenberg, A. (2017). Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors. Arthritis Care and Research, 69(7), 1011-1019. https://doi.org/10.1002/acr.23097